This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Duearity Past Earnings Performance

Past criteria checks 0/6

Duearity's earnings have been declining at an average annual rate of -32.4%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 111.5% per year.

Key information

-32.4%

Earnings growth rate

12.9%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate111.5%
Return on equityn/a
Net Margin-1,812.3%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Duearity makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:9DS Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 242-30270
31 Mar 242-30260
31 Dec 232-26210
30 Sep 231-21130
30 Jun 231-17110
31 Mar 231-17110
31 Dec 220-19130
30 Sep 220-20210
30 Jun 220-20190
31 Mar 220-1890
31 Dec 210-1570
31 Dec 200-220

Quality Earnings: 9DS is currently unprofitable.

Growing Profit Margin: 9DS is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 9DS is unprofitable, and losses have increased over the past 5 years at a rate of 32.4% per year.

Accelerating Growth: Unable to compare 9DS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 9DS is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (16.2%).


Return on Equity

High ROE: 9DS's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies